MENINGOCOCCAL GROUP A C W 135 Y CONJUGATE
Background and Date of Approval
The development of meningococcal conjugate vaccines represented a significant advance in protection against Neisseria meningitidis infections. These vaccines combine purified polysaccharides from the bacterium's outer coating with a carrier protein, generating a stronger and more durable immune response than older polysaccharide-only vaccines. Menactra, the first quadrivalent meningococcal conjugate vaccine (MenACWY), received U.S. FDA approval in 2005. Meningococcal Group A, C, W-135, Y Conjugate was approved in 2010, extending protection against meningococcal serogroups A, C, W-135, and Y across different age groups. MenQuadfi received FDA approval on 23 April 2020 for use in individuals aged 6 weeks and older, positioning it among MenACWY vaccines with broad serogroup coverage. Over time, these conjugate vaccines have superseded older options such as Menomune (MPSV4), owing to their improved and sustained immunogenicity, greater suitability for younger patients, and enhanced utility in outbreak control.
Uses
Prevention of meningococcal meningitis – a serious infection of the membranes surrounding the brain and spinal cord caused by Neisseria meningitidis groups A, C, W-135, and Y. Prevention of meningococcal septicemia (blood poisoning) – a life-threatening infection where the bacteria enter the bloodstream and spread rapidly. Protection for travellers to high-risk areas, such as parts of Africa’s “meningitis belt” or countries requiring proof of vaccination for entry (e.g., Saudi Arabia during Hajj and Umrah). Immunisation of people with certain medical conditions, including those with a weakened immune system, spleen removal (asplenia), or certain complement deficiencies.
Side Effects
Common: Pain, redness, or swelling at the injection site Mild fever Headache Fatigue or tiredness Muscle or joint pain Irritability (in young children) Serious (get medical help immediately): Severe allergic reaction (rash, itching, swelling of face/tongue/throat, difficulty breathing) High fever Seizures Persistent vomiting or unusual behaviour Signs of severe infectio,n such as stiff neck, confusion, or sensitivity to light
Warnings
Given only as an intramuscular (IM) injection by a healthcare professional. The injection site is the deltoid muscle for adults/older children and the anterolateral thigh for infants/toddlers. The standard dose is 0.5 mL, with a schedule based on age and risk factors. High-risk individuals may need a booster every 5 years. Available in single-dose vials or prefilled syringes, with some requiring reconstitution
Precautions
Avoid vaccination if you have a severe allergic reaction to a previous dose or any vaccine component. Postpone vaccination if you have a high fever or serious illness until recovery. Inform your doctor if you have immune system problems or take medicines that weaken immunity. Use with caution in pregnant or breastfeeding women—only if clearly needed and advised by a doctor. Stay under observation for at least 15 minutes after the injection to monitor for allergic reactions.
References
https://www.cdc.gov/vaccines/hcp/current-vis/meningococcal-acwy.html https://www.verywellhealth.com/meningococcal-vaccine-5215620 https://www.drugs.com/sfx/meningococcal-conjugate-vaccine-side-effects.html https://en.wikipedia.org/wiki/Meningococcal_vaccine
Frequently Asked Questions
Can I take the Meningococcal Group A, C, W-135, Y Conjugate Vaccine if I have kidney or liver problems?
Yes, you can usually receive the Meningococcal Group A, C, W-135, Y Conjugate vaccine if you have kidney or liver problems, as it is not processed through these organs like medicines. However, always inform your doctor about your health condition so they can assess safety and timing.
What is the Meningococcal Group A, C, W-135, Y Conjugate Vaccine used for?
It protects against four types of meningococcal bacteria (A, C, W-135, Y) that can cause serious illnesses like meningitis and blood poisoning.
Who should get this vaccine?
It is recommended for people at higher risk, including travelers to certain countries, individuals with weakened immunity, and during outbreak situations.
Can I take the Meningococcal Group A, C, W-135, Y Conjugate Vaccine with other vaccines?
Yes, but your doctor may space them apart depending on the type of other vaccines you are getting.